<b>Results</b>: Network pharmacology identified IL-6, EGFR, TLR4, MMP9, CD44, and IFN-γ as core targets of <b>CCL</b> in ccRCC. The gene discussed is IFNG; the disease is nonpapillary renal cell carcinoma.